Definitive Contract HHSN275201300005C
Award Date
2/15/13
Potential Completion Date
4/30/14
Potential Value
$297K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Astraea Therapeutics LLC
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94043, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $999,993.00 Cost Plus Fixed Fee contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Astraea Therapeutics LLC, a woman-owned small business, for the DEVELOPMENT OF NOCICEPTIN RECEPTOR AGONISTS FOR ALCOHOL USE DISORDERS. The period of performance is September 28, 2015 to September 27, 2017, with a final completion date of March 31, 2018. This contract is part of the SBIR (Small Business Innovation Research) Program Phase II...
This award is for a Small Business Innovation Research (SBIR) Phase I contract to Netrias, LLC, a small business that specializes in AI-driven data harmonization for the life sciences industry. The $224,865 contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development to provide services for synthesizing information to support treatments for alcohol use disorder. This contract is part of the NIH and...
This is a $1,506,619.84 Phase II Small Business Innovation Research (SBIR) contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Policy Research Associates, Inc. (PRA), a Woman-Owned Small Business, for research and development related to physical science. The contract has a period of performance from May 2007 to May 2014. PRA has a history of providing technical assistance, support...
This is a $182,526.96 firm fixed price contract awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to Phoenix Biosystem, Inc., a small disadvantaged business, under the SBIR Program Phase I. The contract is for research and development related to drug dependency management support. The award has a set-aside designation for total small business. The contract was awarded on September 30, 2009 with an ultimate completion date of September 29, 2010.
This is a $6,570,752.65 cost-plus-fixed-fee delivery order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Fast-Track Drugs & Biologics, L.L.C., a woman-owned small business contract research organization (CRO). The contract is for a clinical trial related to the treatment of alcohol use disorder. The contract does not utilize a set-aside designation. Fast-Track Drugs & Biologics has previously...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development awarded a $443,254.48 Small Business Innovation Research (SBIR) Phase I contract to Sugpiat Defense, LLC, an Alaskan Native Corporation-owned firm. The contract is for the development of a wearable biosensor that can quantify blood alcohol concentration in real-time. This SBIR Phase I research effort falls under Topic Area 016 of the NIH's SBIR...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a Small Business Innovation Research (SBIR) Phase I contract to (Ad)2 Technologies, a woman-owned small business, for a wearable alcohol biosensor that quantifies blood alcohol content (BAC) in real-time. The firm-fixed-price contract has a potential value of $499,997.00 and a completion date of July 24, 2020. The SBIR program supports research and...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...
<p>This is a $229,893.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract is for the development of a "MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS." The contract is a definitive, firm-fixed price contract with a completion date of May 14, 2017.</p>
This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...